AMP Annual Meeting 2018: Molecular Tumor Board

Log in for pricing

(No reviews yet) Write a Review
SKU:
311AM18-010

Please note that this content was created in 2018. In the time since this material was posted, there may have been additional developments, advancements, and/or more current publications in this field.

AMP Education is constantly updating our educational offerings, and will remove or replace content that is no longer accurate. Please be sure to use the search function to find related or updated material available in our catalogue at educate.amp.org. The Training and Education Committee works with AMP Education Programs to bring you the most up-to-date and cutting-edge information on molecular pathology research, applications, and training.


This is a recording of a session from the AMP 2018 Annual Meeting & Expo. Purchase the entire AMP Annual Meeting & Expo 2018 Recordings for a significant discount!


Precision medicine demands a team effort to ensure accurate diagnosis, appropriate genomic testing, and integration of tumor and germline genetic findings into a comprehensive plan for optimal patient care. In this session, a multidiscipinary team including pathologists, oncologists, molecular diagnosticians, and informaticians will tackle two real-life clinical challenges. These case-based sessions will examine the performance of different technologies in the detection of challenging but clinically important genomic variants, the critical role of bioinformatics in detection and annotation of DNA variants, and the ultimate clinical implications.

Elizabeth Swisher, MD, University of Washington, Seattle, WA, USA

Stephen Lincoln, Invitae, San Francisco, CA, USA

Eric H. Bernicker, MD, Houston Methodist Hospital, Houston, TX, USA

Valentina Nardi, Massachusetts General Hospital, Boston, MA, USA

Jonathan A. Nowak, MD, PhD, Brigham and Women's Hospital, Boston, MA, USA

Angela Jacobson, MS, University of Washington, Seattle, WA, USA

Objectives:

  • Recognize approaches to detection and interpretation of hereditary cancer predisposition gene variants in adult cancer patients.
  • Summarize technical approaches for the detection of insertion-deletion events using DNA and RNA-based next generation sequencing methods.
  • Discuss best practices for accurate and informative annotation of novel or ambiguous variants. 

Duration: 1.50 hr
Recording Date: November 1, 2018

Last day to purchase: December 31, 2021

There are no CME/CMLE or SAMs credits available.

Note: Join the AMP Family for discounted access to the most current educational resources!

All sales are final. No refunds will be issued.

No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.